Journal: Frontiers in Pharmacology
Article Title: Hydroxysafflor yellow A attenuates sepsis-induced intestinal barrier dysfunction by modulating Bcl-2/SOD2-mediated mitochondrial apoptosis
doi: 10.3389/fphar.2026.1728183
Figure Lengend Snippet: Molecular Docking, Molecular Dynamics Analysis, and in vitro / in vivo Validation of Key Proteins. (A) Chemical structure of HSYA. (B) Venn diagram integrating sepsis-, HSYA-, and apoptosis-related targets, highlighting Bcl-2 and SOD2 as key molecules. (C) Molecular docking and molecular dynamics analysis showing binding interactions of HSYA with Bcl-2. (D) Molecular docking and molecular dynamics analysis showing binding interactions of HSYA with SOD2. (E) Western blot analysis of Bcl-2 and SOD2 protein expression in IEC-6 cells (n = 3). (F) Western blot analysis of Bcl-2 and SOD2 protein expression in intestinal tissues (n = 3).
Article Snippet: The rat intestinal epithelial cell line IEC-6 (ATCC, USA) was maintained in Dulbecco’s Modified Eagle Medium (DMEM; Hyclone, USA) supplemented with 10% fetal bovine serum (FBS; Hyclone, USA) under standard conditions (37 °C, 5% CO 2 , humidified incubator).
Techniques: In Vitro, In Vivo, Biomarker Discovery, Binding Assay, Western Blot, Expressing